Skip to main content
TYK Medicines, Inc logo

TYK Medicines, Inc — Investor Relations & Filings

Ticker · 2410 ISIN · CNE100006L34 HKEX Manufacturing
Open in API
Filings indexed 871 across all filing types
Latest filing 2024-12-03 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2410

About TYK Medicines, Inc

https://www.tykmedicines.com

TYK Medicines, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule targeted therapies. The company leverages a proprietary small molecule drug design and screening platform, with a primary strategic focus on oncology, particularly treatments for lung cancer. The lead pipeline asset, TY-9591 (Edotamidine mesylate), an EGFR-targeted therapy, is currently in the Pre-NDA stage, having demonstrated promising clinical efficacy in treating lung cancer patients with brain metastasis. The pipeline also includes assets such as TY-302 and TY-2136, alongside multiple CDK inhibitors in clinical development, reflecting a commitment to addressing unmet medical needs in targeted cancer treatment.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
Regulatory Filings Classification · 85% confidence The document is a Form FF301 monthly return filed to the HKEX under Listing Rule Chapter 19B, detailing movements in issued shares and depositary receipts for the month ending 30 November 2024. It is not an annual or interim report, earnings release, capital raising, or other specific category. It is a routine regulatory submission of share movements that does not fit into other predefined categories, so it defaults to a general regulatory filing.
2024-12-03 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2024
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 October 2024. It details movements in authorized/registered share capital, issued shares, treasury shares, and confirms no changes in share options, warrants, convertibles, or other agreements to issue shares. The document is submitted to the Hong Kong Exchanges and Clearing Limited and is a regulatory compliance filing related to share capital and share movements. It does not contain financial statements, earnings data, management discussion, or audit information. It is a regulatory announcement about share capital and share movements, fitting the category of Share Issue/Capital Change announcements rather than a full report or other categories.
2024-11-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 October 2024. It details movements in issued shares, treasury shares, share options, warrants, convertibles, and other agreements related to share issuance. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital movements and confirmations. It is not a full financial report, earnings release, or management discussion. It is a regulatory filing related to share capital movements but does not announce a new share issue or capital change per se, nor is it a proxy or voting result. Given the nature and length (under 5,000 characters) and the detailed reporting of share movements, this fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories like SHA or POS, which are for announcements of new share issues or share repurchases. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2024-11-01 English
CHANGE OF COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
Board/Management Information Classification · 100% confidence The document is an announcement from Namyue Holdings Limited regarding a change in company secretary and authorised representative. It details the resignation of Ms. Cheung Hoi Yin and the appointment of Ms. Chan Miu Ting, including their qualifications and tenure. There is no financial data, report, or regulatory filing referenced beyond the personnel change. The content focuses solely on management changes at the board or senior management level. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 3576 characters, which is relatively short but contains substantive information about management changes, not just a brief notice or report publication announcement. Therefore, the appropriate classification is MANG with high confidence.
2024-10-17 English
UNAUDITED FINANCIAL INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024
Interim / Quarterly Report Classification · 95% confidence The document is titled 'UNAUDITED FINANCIAL INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024' and contains detailed financial data including revenue, consolidated loss, total assets, and shareholders' equity for the nine-month period ending 30 September 2024. It explicitly states that the financial information is unaudited and is for a period shorter than a full fiscal year. The document includes performance highlights and operational data, indicating substantive financial data and analysis. It is not a full annual report (10-K) but an interim report covering nine months. The length of the document (7780 characters) and the detailed financial content confirm it is a comprehensive interim/quarterly report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2024
2024-10-17 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from Namyue Holdings Limited regarding the scheduling of a board meeting to consider and approve the unaudited financial information for the nine months ended 30 September 2024. It does not contain the financial information itself but only announces the date of the board meeting. The document is short (1372 characters) and serves as a notice rather than a report. According to the 'MENU VS MEAL' rule, such announcements about upcoming report approvals are classified as Regulatory Filings (RNS) rather than the actual Interim/Quarterly Report (IR).
2024-10-03 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.